bluebird bio, Inc. - stock earnings
BLUE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -71.7 million USD | 12.4 million USD |
| 2023Q2 | -72.9 million USD | 6.9 million USD |
| 2023Q1 | 34.0 million USD | 2.4 million USD |
| 2022Q4 | 32.2 million USD | 62000 USD |
| 2022Q3 | -76.5 million USD | 71000 USD |
| 2022Q2 | -92.9 million USD | 1.5 million USD |
| 2022Q1 | -124.0 million USD | 1.9 million USD |
| 2021Q4 | -155.1 million USD | 1.6 million USD |
| 2021Q3 | -216.8 million USD | 22.7 million USD |
| 2021Q2 | -241.7 million USD | 7.5 million USD |
| 2021Q1 | -205.8 million USD | 12.8 million USD |
| 2020Q4 | -199.9 million USD | 10.7 million USD |
| 2020Q3 | -194.7 million USD | 19.3 million USD |
| 2020Q2 | -21.5 million USD | 198.9 million USD |
| 2020Q1 | -202.6 million USD | 21.9 million USD |
| 2019Q4 | -223.3 million USD | 10.0 million USD |
| 2019Q3 | -206.0 million USD | 8.9 million USD |
| 2019Q2 | -195.8 million USD | 13.3 million USD |
| 2019Q1 | -164.4 million USD | 12.5 million USD |
| 2018Q4 | -149.0 million USD | 19.2 million USD |
| 2018Q3 | -145.5 million USD | 11.5 million USD |
| 2018Q2 | -146.0 million USD | 7.9 million USD |
| 2018Q1 | -115.1 million USD | 16.0 million USD |
| 2017Q4 | -117.2 million USD | 4.2 million USD |
| 2017Q3 | -78.8 million USD | 7.7 million USD |
| 2017Q2 | -70.9 million USD | 16.7 million USD |
| 2017Q1 | -68.7 million USD | 6.8 million USD |
| 2016Q4 | -71.4 million USD | 1.6 million USD |
| 2016Q3 | -77.0 million USD | 1.6 million USD |
| 2016Q2 | -58.8 million USD | 1.6 million USD |
| 2016Q1 | -56.3 million USD | 1.5 million USD |
| 2015Q4 | -47.3 million USD | 1.5 million USD |
| 2015Q3 | -42.9 million USD | 1.3 million USD |
| 2015Q2 | -51.8 million USD | 4.9 million USD |
| 2015Q1 | -24.8 million USD | 6.3 million USD |
| 2014Q4 | -19.5 million USD | 6.4 million USD |
| 2014Q3 | -17.0 million USD | 6.4 million USD |
| 2014Q2 | -1.5 million USD | 6.3 million USD |
| 2014Q1 | -10.6 million USD | 6.3 million USD |
| 2013Q4 | -8.1 million USD | 6.3 million USD |
| 2013Q3 | -6.1 million USD | 6.4 million USD |
| 2013Q2 | -4.6 million USD | 6.3 million USD |
| 2013Q1 | -6.5 million USD | 1.1 million USD |
| 2012Q4 | -9.0 million USD | 85000 USD |
| 2012Q3 | -5.0 million USD | 85000 USD |
| 2012Q2 | -4.6 million USD | 85000 USD |
| 2012Q1 | -5.1 million USD | 85000 USD |
| 2011Q4 | ? USD | 882000 USD |
BLUE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -91.2 million USD | 21.7 million USD |
| 2022 | -266.6 million USD | 3.6 million USD |
| 2021 | -562.6 million USD | 3.7 million USD |
| 2020 | -618.7 million USD | 250.7 million USD |
| 2019 | -789.6 million USD | 44.7 million USD |
| 2018 | -555.6 million USD | 54.6 million USD |
| 2017 | -335.6 million USD | 35.4 million USD |
| 2016 | -263.5 million USD | 6.2 million USD |
| 2015 | -166.8 million USD | 14.1 million USD |
| 2014 | -48.7 million USD | 25.4 million USD |
| 2013 | -25.3 million USD | 20.2 million USD |
| 2012 | -23.7 million USD | 340000 USD |
| 2011 | -15.6 million USD | 882000 USD |
BLUE
Price: $0.92
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.63 USD
P/E Ratio: -1.52
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 3.0 million
Ebitda: -74.0 millionMarket Capitalization: 227.4 million